525 related articles for article (PubMed ID: 34907642)
1. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.
Khashkhashi Moghadam S; Bakhshinejad B; Khalafizadeh A; Mahmud Hussen B; Babashah S
J Cell Mol Med; 2022 Jan; 26(2):287-305. PubMed ID: 34907642
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
[TBL] [Abstract][Full Text] [Related]
4. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.
Tian Y; Zhang M; Liu LX; Wang ZC; Liu B; Huang Y; Wang X; Ling YZ; Wang F; Feng X; Tu Y
Front Immunol; 2024; 15():1400744. PubMed ID: 38799446
[TBL] [Abstract][Full Text] [Related]
5. Functional long non-coding RNAs in hepatocellular carcinoma.
Xie C; Li SY; Fang JH; Zhu Y; Yang JE
Cancer Lett; 2021 Mar; 500():281-291. PubMed ID: 33129957
[TBL] [Abstract][Full Text] [Related]
6. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
Front Immunol; 2022; 13():985815. PubMed ID: 36300115
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
8. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.
Shi T; Morishita A; Kobara H; Masaki T
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
[TBL] [Abstract][Full Text] [Related]
10. Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma.
Zhang Q; Li H; Liu Y; Li J; Wu C; Tang H
Curr Oncol; 2022 Jul; 29(8):5383-5406. PubMed ID: 36005165
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
13. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma.
Niu ZS; Wang WH; Dong XN; Tian LM
World J Gastroenterol; 2020 Aug; 26(29):4240-4260. PubMed ID: 32848331
[TBL] [Abstract][Full Text] [Related]
14. Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives.
Hussain MS; Moglad E; Afzal M; Gupta G; Hassan Almalki W; Kazmi I; Alzarea SI; Kukreti N; Gupta S; Kumar D; Chellappan DK; Singh SK; Dua K
Pathol Res Pract; 2024 Jun; 258():155303. PubMed ID: 38728793
[TBL] [Abstract][Full Text] [Related]
15. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma.
Lim LJ; Wong SYS; Huang F; Lim S; Chong SS; Ooi LL; Kon OL; Lee CG
Cancer Res; 2019 Oct; 79(20):5131-5139. PubMed ID: 31337653
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
Zhao J; Wang Y; Su H; Su L
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
[TBL] [Abstract][Full Text] [Related]
17. Role of miRNA sponges in hepatocellular carcinoma.
Li D; Zhang J; Li J
Clin Chim Acta; 2020 Jan; 500():10-19. PubMed ID: 31604064
[TBL] [Abstract][Full Text] [Related]
18. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
19. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC.
Rusu I; Pirlog R; Chiroi P; Nutu A; Puia VR; Fetti AC; Rusu DR; Berindan-Neagoe I; Al Hajjar N
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293225
[TBL] [Abstract][Full Text] [Related]
20. Decoding hepatocarcinogenesis from a noncoding RNAs perspective.
El-Aziz MKA; Dawoud A; Kiriacos CJ; Fahmy SA; Hamdy NM; Youness RA
J Cell Physiol; 2023 Sep; 238(9):1982-2009. PubMed ID: 37450612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
